Fingerprint
Dive into the research topics of 'Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically